JULIE BARNARD: Open Payments
NPI 1649555384 · GREENVILLE, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,056 in 56 payments from 16 companies in 2025. Trend: 2023 $860 · 2024 $1,195 · 2025 $1,056
Food & beverage: $1,056
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 18 | $308 |
| Otsuka America Pharmaceutical, Inc. | 5 | $114 |
| Novo Nordisk Inc | 4 | $95 |
| Amgen Inc. | 5 | $92 |
| Abbott Laboratories | 3 | $63 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $59 |
| Axsome Therapeutics, Inc. | 3 | $56 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $51 |
| PFIZER INC. | 2 | $38 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $35 |
Products named: AIRSUPRA, REXULTI, BREZTRI, EVENITY, FREESTYLE LIBRE 3, TRINTELLIX, CAPLYTA, Ozempic.
Industry payments across TX — which companies pay providers there.
